BioPorto is a global in-vitro diagnostics company that provides tests and antibodies to clinicians and researchers. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. Headquartered in Hellerup, Denmark, with US headquarters outside Boston, Massachusetts, BioPorto is listed on the NASDAQ Copenhagen stock exchange. [CPH: BIOPOR] To learn more about our products and their availability in your country, visit bioporto.com or follow our LinkedIn pages: Outside the United States: https://www.linkedin.com/company/bioporto-diagnostics-a-s/ Within the US: https://www.linkedin.com/company/bioporto-diagnostics-inc-us/ Social Media Community Guidelines: https://bioporto.com/social-media/
